Analyst Activity – Citigroup Lowers Its Price Target On NYSE:ABT – Abbott Laboratories (NYSE:ABT) to $65.00

ME Staff
-
0

Analyst Ratings For NYSE:ABT – Abbott Laboratories (NYSE:ABT)

Today, Citigroup lowered its price target on NYSE:ABT – Abbott Laboratories (NYSE:ABT) to $65.00 per share.

Some recent analyst ratings include

  • 4/22/2018-BTIG Research Reiterated Rating of Hold.
  • 1/25/2018-Guggenheim Reiterated Rating of Buy.
  • 1/25/2018-Royal Bank of Canada Reiterated Rating of Buy.
  • 1/25/2018-Leerink Swann Reiterated Rating of Market Perform.

Dividend information for NYSE:ABT – Abbott Laboratories (NYSE:ABT)

NYSE:ABT – Abbott Laboratories (NYSE:ABT) pays an annual dividend of $1.12 with a yield of 1.92% and an average dividend growth of 6.40% based on a 3 Year Average..

Dividend History for NYSE:ABT – Abbott Laboratories (NYSE:ABT)

  • On 2/16/2018 NYSE:ABT – Abbott Laboratories announced a quarterly dividend of $0.28 1.85415114642828% with an ex dividend date of 4/12/2018 which will be payable on 5/15/2018.
  • On 12/15/2017 NYSE:ABT – Abbott Laboratories announced a quarterly dividend of $0.28 1.99% with an ex dividend date of 1/11/2018 which will be payable on 2/15/2018.
  • On 9/15/2017 NYSE:ABT – Abbott Laboratories announced a quarterly dividend of $0.2650 2.05% with an ex dividend date of 10/12/2017 which will be payable on 11/15/2017.
  • On 6/9/2017 NYSE:ABT – Abbott Laboratories announced a quarterly dividend of $0.2650 2.25% with an ex dividend date of 7/12/2017 which will be payable on 8/15/2017.
  • On 2/17/2017 NYSE:ABT – Abbott Laboratories announced a quarterly dividend of $0.2650 2.36% with an ex dividend date of 4/11/2017 which will be payable on 5/15/2017.
  • On 12/9/2016 NYSE:ABT – Abbott Laboratories announced a quarterly dividend of $0.2650 2.7% with an ex dividend date of 1/11/2017 which will be payable on 2/15/2017.
  • On 9/15/2016 NYSE:ABT – Abbott Laboratories announced a quarterly dividend of $0.26 2.48% with an ex dividend date of 10/12/2016 which will be payable on 11/15/2016.

Recent Insider Trading Activity For NYSE:ABT – Abbott Laboratories (NYSE:ABT)
NYSE:ABT – Abbott Laboratories (NYSE:ABT) has insider ownership of 0.74% and institutional ownership of 72.32%.

  • On 3/9/2018 Roger Bird, Insider, sold 8,262 with an average share price of $62.75 per share and the total transaction amounting to $518,440.50.
  • On 3/7/2018 Jared Watkin, Insider, sold 3,000 with an average share price of $61.19 per share and the total transaction amounting to $183,570.00.
  • On 3/5/2018 Sharon J Bracken, SVP, sold 2,100 with an average share price of $60.27 per share and the total transaction amounting to $126,567.00.
  • On 3/1/2018 Jared Watkin, SVP, sold 996 with an average share price of $58.87 per share and the total transaction amounting to $58,634.52.
  • On 3/1/2018 Sharon J Bracken, Insider, sold 1,053 with an average share price of $58.93 per share and the total transaction amounting to $62,053.29.
  • On 3/1/2018 Stephen R Fussell, EVP, sold 11,106 with an average share price of $60.13 per share and the total transaction amounting to $667,803.78.
  • On 2/27/2018 Daniel J Starks, Director, bought 40,037 with an average share price of $60.67 per share and the total transaction amounting to $2,429,044.79.

Recent Trading Activity for NYSE:ABT – Abbott Laboratories (NYSE:ABT)
Shares of NYSE:ABT – Abbott Laboratories closed the previous trading session at 58.19 down -0.65 1.10% with 59.09000015258789 shares trading hands.